New pill for cystic fibrosis lung disease tested in small trial

NCT ID NCT05865886

Completed Disease control Sponsor: Boehringer Ingelheim Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new medicine called BI 1291583 in 22 adults with cystic fibrosis bronchiectasis, a lung condition that causes coughing and infections. Participants took one tablet daily for 12 weeks, and the study checked if the medicine was safe and well-tolerated. The trial was completed and aimed to gather early safety data.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bronchiectasis cystic fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRONCHIECTASIS CYSTIC FIBROSIS

Contacts and locations

Locations

AOU San Luigi Gonzaga

Orbassano (TO), 10043, Italy
Amsterdam UMC, location VUMC

Amsterdam, 1081 HV, Netherlands
Azienda Ospedaliera Meyer

Florence, 50139, Italy
Azienda Ospedaliera Universitaria Integrata Verona

Verona, 37126, Italy
Brussels - UNIV UZ Brussel

Brussels, 1090, Belgium
Central Florida Pulmonary Group

Altamonte Springs, Florida, 32701, United States
Charité - Universitätsmedizin Berlin

Berlin, 13353, Germany
Chest Medicine Associates

South Portland, Maine, 04106, United States
Columbia University Medical Center-New York Presbyterian Hospital

New York, New York, 10032, United States
HOP Arnaud de Villeneuve

Montpellier, 34295, France
Hospital Universitari Vall d'Hebron

Barcelona, 08035, Spain
Hospital Universitario Ramon Y Cajal

Madrid, 28049, Spain
Hôpital Charles Nicolle

Rouen, 76031, France
Hôpital Cochin

Paris, 75679, France
IRCCS Fondazione Ospedale Maggiore

Milan, 20122, Italy
Istituto G. Gaslini

Genova, 16147, Italy
Klinikum der Universität München AÖR

München, 80336, Germany
Medical University of South Carolina

Charleston, South Carolina, 29425, United States
Medizinische Hochschule Hannover

Hanover, 30625, Germany
National Jewish Health

Denver, Colorado, 80206, United States
Northwell Health Physician Partners

New York, New York, 10028, United States
Oregon Health and Sciences University

Portland, Oregon, 97239, United States
Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH

Essen, 45239, Germany
Universitair Medisch Centrum Utrecht

Utrecht, 3584 CX, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.